Home › Trial NCT01626495
Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
- Trial IDNCT01626495
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorUniversity of Pennsylvania
- Enrollment73
- Start date2011-08-17
- ConditionsB Cell Leukemia · B Cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.